Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N H Russell

Showing results (91-100 of 156) with videos related to

Pageof 16
Sort By:
Transfusion Medicine (Oxford, England)|December 20, 2005
Low dose erythropoietin is effective in reducing transfusion requirements following allogeneic HSCTC P Fox, S Pacey, E P Das-Gupta, et al.
British Journal of Haematology|February 5, 1998
Allogeneic bone marrow transplantation for systemic AL amyloidosisJ D Gillmore, J Davies, A Iqbal, et al.
British Journal of Haematology|March 2, 1999
Use of standardized flow cytometric determinants of multidrug resistance to analyse response to remission induction chemotherapy in patients with acute myeloblastic leukaemiaM Pallis, J Turzanski, G Harrison, et al.
British Journal of Haematology|December 1, 1989
Pregnancy associated aplastic anaemia: a report of five cases and review of current managementR G Aitchison, J C Marsh, J M Hows, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Low-dose filgrastim significantly enhances neutrophil recovery following autologous peripheral-blood stem-cell transplantation in patients with lymphoproliferative disorders: evidence for clinical and economic benefitI G McQuaker, A E Hunter, S Pacey, et al.
British Journal of Haematology|July 21, 2005
Uptake of high-dose therapy and peripheral blood stem cell transplantation in myeloma patients <65 years--the role of the myeloma multi-disciplinary teamK Saravanamuttu, J L Byrne, C Williams, et al.
Bone Marrow Transplantation|March 7, 2003
Allogeneic transplantation for multiple myeloma: late relapse may occur as localised lytic lesion/plasmacytoma despite ongoing molecular remissionJ L Byrne, J Fairbairn, B Davy, et al.
British Journal of Haematology|August 1, 1982
The effect of deoxycoformycin and deoxyadenosine on deoxyribonucleotide concentrations in leukaemic cellsT Sylwestrowicz, A Piga, P Murphy, et al.
British Journal of Haematology|December 3, 1999
Comparative serial quantitative measurements of chimaerism following unmanipulated allogeneic transplantation of peripheral blood stem cells and bone marrowG Miflin, C J Stainer, G I Carter, et al.
British Journal of Haematology|February 27, 2004
The use of a national transplant registry to benchmark transplant outcome for patients undergoing autologous and allogeneic stem cell transplantation in the United Kingdom and IrelandN H Russell, R Szydlo, S McCann, et al.
Pageof 16

Showing results (91-100 of 156) with videos related to

Sort By:
Pageof 16
Transfusion Medicine (Oxford, England)|December 20, 2005
Low dose erythropoietin is effective in reducing transfusion requirements following allogeneic HSCTC P Fox, S Pacey, E P Das-Gupta, et al.
British Journal of Haematology|February 5, 1998
Allogeneic bone marrow transplantation for systemic AL amyloidosisJ D Gillmore, J Davies, A Iqbal, et al.
British Journal of Haematology|March 2, 1999
Use of standardized flow cytometric determinants of multidrug resistance to analyse response to remission induction chemotherapy in patients with acute myeloblastic leukaemiaM Pallis, J Turzanski, G Harrison, et al.
British Journal of Haematology|December 1, 1989
Pregnancy associated aplastic anaemia: a report of five cases and review of current managementR G Aitchison, J C Marsh, J M Hows, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Low-dose filgrastim significantly enhances neutrophil recovery following autologous peripheral-blood stem-cell transplantation in patients with lymphoproliferative disorders: evidence for clinical and economic benefitI G McQuaker, A E Hunter, S Pacey, et al.
British Journal of Haematology|July 21, 2005
Uptake of high-dose therapy and peripheral blood stem cell transplantation in myeloma patients <65 years--the role of the myeloma multi-disciplinary teamK Saravanamuttu, J L Byrne, C Williams, et al.
Bone Marrow Transplantation|March 7, 2003
Allogeneic transplantation for multiple myeloma: late relapse may occur as localised lytic lesion/plasmacytoma despite ongoing molecular remissionJ L Byrne, J Fairbairn, B Davy, et al.
British Journal of Haematology|August 1, 1982
The effect of deoxycoformycin and deoxyadenosine on deoxyribonucleotide concentrations in leukaemic cellsT Sylwestrowicz, A Piga, P Murphy, et al.
British Journal of Haematology|December 3, 1999
Comparative serial quantitative measurements of chimaerism following unmanipulated allogeneic transplantation of peripheral blood stem cells and bone marrowG Miflin, C J Stainer, G I Carter, et al.
British Journal of Haematology|February 27, 2004
The use of a national transplant registry to benchmark transplant outcome for patients undergoing autologous and allogeneic stem cell transplantation in the United Kingdom and IrelandN H Russell, R Szydlo, S McCann, et al.
Pageof 16